For the three-month periods ended June 30, 2022 and 2021, our total stock-based compensation expense, which includes reversals of expense for certain forfeited or cancelled awards, was $40,555 and $142,180, respectively. For the six-month periods ended June 30, 2022 and 2021, our total stock-based compensation expense, which includes reversals of expense for certain forfeited or cancelled awards, was approximately $225,405 and $263,478, respectively. We have not recorded any income tax benefit related to stock-based compensation in any of the three-month or six-month periods ended June 30, 2022 and 2021.

A summary of the status of our stock options as of June 30, 2022, and changes during the six-month period then ended, is presented below.

The weighted average grant date fair value per stock option granted during the six-month period ended June 30, 2022 was $0.65. Key assumptions used in the Black-Scholes option pricing model for stock options granted during the six-month period ended June 30, 2022 were the Company’s stock price, an expected volatility rate of 93.94%, a risk-free rate of 2.34%, and an expected life of 6.25 years. 

A summary of the status of our unvested restricted stock as of June 30, 2022, and changes during the six-month period then ended, is presented below.

As of June 30, 2022, there was $136,148 of total unrecognized compensation expense related to unvested stock-based awards, which we expect to recognize over the remaining weighted average vesting term of 1.6 years.